Long-Term Follow-Up In Paroxysmal Atrial Fibrillation Patients With Documented Isolated Trigger
- PMID: 37529713
- PMCID: PMC10390222
- DOI: 10.3389/fcvm.2023.1115328
Long-Term Follow-Up In Paroxysmal Atrial Fibrillation Patients With Documented Isolated Trigger
Abstract
Aims: Supraventricular tachycardias may trigger atrial fibrillation (AF). The aim of the study was to evaluate the prevalence of supraventricular tachycardia (SVT) inducibility in patients referred for AF ablation and to evaluate the effects of SVT ablation on AF recurrences.
Methods and results: 249 patients (mean age: 54 ± 14 years) referred for paroxysmal AF ablation were studied. In all patients, only AF relapses had been documented in the clinical history. 47 patients (19%; mean age: 42 ± 11 years) had inducible SVT during the electrophysiological study and underwent an ablation targeted only at SVT suppression. Ablation was successful in all 47 patients. The ablative procedures were: 11 slow-pathway ablations for atrioventricular nodal re-entrant tachycardia; 6 concealed accessory pathway ablations for atrioventricular re-entrant tachycardia; 17 focal ectopic atrial tachycardia ablations; 13 with only one arrhythmogenic pulmonary vein. No recurrences of SVT were observed during the follow-up (32 ± 18 months). 4 patients (8.5%) showed recurrence of at least one episode of AF. Patients with inducible SVT had less structural heart disease and were younger than those without inducible SVT.
Conclusion: A significant proportion of candidates for AF ablation are inducible for an SVT. SVT ablation showed a preventive effect on AF recurrences. Those patients should be selected for simpler ablation procedures tailored only to the triggering arrhythmia suppression.
Keywords: PVI catheter ablation; PVI only; atrial fibrillation ablation; supraventricular tachycardia; tailored approach.
© 2023 Palamà, Robles, Paoletti, Nesti, De Ruvo, Scarà, Borrelli, De Masi De Luca, Rillo, Calò, Cavarretta, Romano and Sciarra.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Catheter Ablation for Atrial Fibrillation in Patients ≤30 Years of Age.Am J Cardiol. 2022 Mar 1;166:53-57. doi: 10.1016/j.amjcard.2021.11.020. Epub 2021 Dec 30. Am J Cardiol. 2022. PMID: 34973688
-
Inducible supraventricular tachycardias in patients referred for catheter ablation of atrial fibrillation.Europace. 2007 Sep;9(9):785-9. doi: 10.1093/europace/eum105. Epub 2007 Jun 1. Europace. 2007. PMID: 17545655
-
Atrial Fibrillation Inducibility After Ablation of Paroxysmal Supraventricular Tachycardia.CJC Open. 2025 Apr 19;7(7):907-912. doi: 10.1016/j.cjco.2025.03.027. eCollection 2025 Jul. CJC Open. 2025. PMID: 40698299 Free PMC article.
-
[Catheter ablation in supraventricular tachycardia].Z Kardiol. 1996;85 Suppl 6:45-60. Z Kardiol. 1996. PMID: 9064982 Review. German.
-
Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.Ann Acad Med Singap. 1998 Mar;27(2):248-54. Ann Acad Med Singap. 1998. PMID: 9663319 Review.
Cited by
-
Prevalence and Risk Factors of Postprocedure Depression in Patients with Atrial Fibrillation after Radiofrequency Ablation.Cardiol Res Pract. 2023 Nov 7;2023:4635336. doi: 10.1155/2023/4635336. eCollection 2023. Cardiol Res Pract. 2023. PMID: 38020945 Free PMC article.
-
Ablation of Paroxysmal Atrial Fibrillation: between Present and Future.Rev Cardiovasc Med. 2024 Apr 8;25(4):140. doi: 10.31083/j.rcm2504140. eCollection 2024 Apr. Rev Cardiovasc Med. 2024. PMID: 39076570 Free PMC article. Review.
-
Editorial: Pharmacological therapy in patients with arrhythmias.Front Pharmacol. 2024 Jul 25;15:1465539. doi: 10.3389/fphar.2024.1465539. eCollection 2024. Front Pharmacol. 2024. PMID: 39119612 Free PMC article. No abstract available.
-
Effective superior vena cava isolation using a novel C-shaped approach.Front Cardiovasc Med. 2023 Sep 15;10:1253912. doi: 10.3389/fcvm.2023.1253912. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37781302 Free PMC article.
-
Thromboembolic prevention in athletes: management of anticoagulation in sports players affected by atrial fibrillation.Front Pharmacol. 2024 May 10;15:1384213. doi: 10.3389/fphar.2024.1384213. eCollection 2024. Front Pharmacol. 2024. PMID: 38803430 Free PMC article. Review.
References
-
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. (2021) 42:373–498. 10.1093/eurheartj/ehaa612 - DOI - PubMed
LinkOut - more resources
Full Text Sources